Fig. 5: Adjuvant chemotherapy benefits based on DMFS according to pT stage and RS.
From: Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer
a–c K–M DMFS curves are shown for patients according to their use of adjuvant chemotherapy. In addition, patients with a high RS (left) were stratified according to pT0 (n = 23, upper), pT1–2 (n = 49, middle), and pT3–4 (n = 207, bottom). Patients with a low RS (right) were also stratified according to pT0 (n = 43, upper), pT1–2 (n = 57, middle), and pT3–4 (n = 250, bottom). p values were calculated using two-sided log-rank test. RS radiomic signature; HR hazard ratio; DMFS distant metastasis-free survival; LARC locally advanced rectal cancer. Source data are provided as a Source Data file.
